Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
Bulletin of the World Health Organization
|
January 1, 1994
Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison
C P Thakur, G P Sinha, A K Pandey, et al.
The National Medical Journal of India
|
March 1, 1993
Amphotericin B in resistant kala-azar in Bihar
C P Thakur, G P Sinha, A K Pandey, et al.
British Journal of Rheumatology
|
December 24, 1997
Pachydermoperiostosis in childhood
G P Sinha, P Curtis, D Haigh, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
May 1, 1996
Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study
C P Thakur, A K Pandey, G P Sinha, et al.
The Indian Journal of Medical Research
|
July 1, 1993
Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar
C P Thakur, G P Sinha, V Sharma, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
December 29, 2000
Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study
C P Thakur, T P Kanyok, A K Pandey, et al.
Indian Journal of Pediatrics
|
January 1, 1993
Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life
C P Thakur, G P Sinha, V Sharma, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
December 29, 2000
A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis
C P Thakur, T P Kanyok, A K Pandey, et al.
Annals of Tropical Medicine and Parasitology
|
November 3, 1998
Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases
C P Thakur, G P Sinha, A K Pandey, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
Bulletin of the World Health Organization
|
January 1, 1994
Daily versus alternate-day regimen of amphotericin B in the treatment of kala-azar: a randomized comparison
C P Thakur, G P Sinha, A K Pandey, et al.
The National Medical Journal of India
|
March 1, 1993
Amphotericin B in resistant kala-azar in Bihar
C P Thakur, G P Sinha, A K Pandey, et al.
British Journal of Rheumatology
|
December 24, 1997
Pachydermoperiostosis in childhood
G P Sinha, P Curtis, D Haigh, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
May 1, 1996
Comparison of three treatment regimens with liposomal amphotericin B (AmBisome) for visceral leishmaniasis in India: a randomized dose-finding study
C P Thakur, A K Pandey, G P Sinha, et al.
The Indian Journal of Medical Research
|
July 1, 1993
Evaluation of amphotericin B as a first line drug in comparison to sodium stibogluconate in the treatment of fresh cases of kala-azar
C P Thakur, G P Sinha, V Sharma, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
December 29, 2000
Treatment of visceral leishmaniasis with injectable paromomycin (aminosidine). An open-label randomized phase-II clinical study
C P Thakur, T P Kanyok, A K Pandey, et al.
Indian Journal of Pediatrics
|
January 1, 1993
Efficacy of amphotericin B in multi-drug resistant kala-azar in children in first decade of life
C P Thakur, G P Sinha, V Sharma, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene
|
December 29, 2000
A prospective randomized, comparative, open-label trial of the safety and efficacy of paromomycin (aminosidine) plus sodium stibogluconate versus sodium stibogluconate alone for the treatment of visceral leishmaniasis
C P Thakur, T P Kanyok, A K Pandey, et al.
Annals of Tropical Medicine and Parasitology
|
November 3, 1998
Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases
C P Thakur, G P Sinha, A K Pandey, et al.
Page
of 2